David C.
- Country
- France
- Department
- Neurovasculaire
Research Overview
- Efficacy of Apixaban Versus Standard Care in Patients with Intracerebral Hemorrhage: A Randomized Controlled Trial
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- Evaluation of Peripheral Dilute Norepinephrine for Functional Independence in Acute Progressive Perforating Artery Stroke
Data & Insights
Has run more than one trial at 46 of 327 partner sites.
Specializations
Cerebrovascular Medicine
The investigator specializes in treating acute stroke conditions and their complications, with particular focus on intracerebral hemorrhage management.
- Hemorrhagic Stroke Treatment
- Post-stroke Anticoagulation
- Acute Stroke Intervention
Their work addresses critical aspects of stroke care, including bleeding management and prevention strategies.
Neurological Disorders
Expertise extends to progressive perforating artery stroke and the development of innovative treatment approaches using blood pressure modulation.
- Ischemic Stroke Management
- Transient Ischemic Attack
- Neurological Deterioration
The investigator explores various therapeutic interventions for acute neurological conditions.
Hematological Conditions
The investigator's expertise includes treatment of sickle cell disease and its complications, with focus on intravascular hemolysis.
- Blood Disorders
- Hemolysis Management
- Organ Damage Prevention
Their work encompasses therapeutic approaches for blood-related disorders and their systemic effects.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.